These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 8860681)
1. Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. Chouly C; Pouliquen D; Lucet I; Jeune JJ; Jallet P J Microencapsul; 1996; 13(3):245-55. PubMed ID: 8860681 [TBL] [Abstract][Full Text] [Related]
2. A novel formulation for superparamagnetic iron oxide (SPIO) particles enhancing MR lymphography: comparison of physicochemical properties and the in vivo behaviour. Lind K; Kresse M; Debus NP; Müller RH J Drug Target; 2002 May; 10(3):221-30. PubMed ID: 12075823 [TBL] [Abstract][Full Text] [Related]
3. Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Matuszewski L; Persigehl T; Wall A; Schwindt W; Tombach B; Fobker M; Poremba C; Ebert W; Heindel W; Bremer C Radiology; 2005 Apr; 235(1):155-61. PubMed ID: 15749976 [TBL] [Abstract][Full Text] [Related]
4. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Jung CW; Jacobs P Magn Reson Imaging; 1995; 13(5):661-74. PubMed ID: 8569441 [TBL] [Abstract][Full Text] [Related]
5. [Transmission electron microscopy in the structural study of superparamagnetic contrast agents for MRI]. Lucet I; Filmon R; Pouliquen D; Le Jeune JJ; Jallet P Bull Assoc Anat (Nancy); 1994 Mar; 78(240):57-9. PubMed ID: 7519906 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of ultrasmall superparamagnetic iron oxides using reduced polysaccharides. Paul KG; Frigo TB; Groman JY; Groman EV Bioconjug Chem; 2004; 15(2):394-401. PubMed ID: 15025537 [TBL] [Abstract][Full Text] [Related]
7. Clearance of iron oxide particles in rat liver: effect of hydrated particle size and coating material on liver metabolism. Briley-Saebo KC; Johansson LO; Hustvedt SO; Haldorsen AG; Bjørnerud A; Fayad ZA; Ahlstrom HK Invest Radiol; 2006 Jul; 41(7):560-71. PubMed ID: 16772849 [TBL] [Abstract][Full Text] [Related]
8. Liver-directed superparamagnetic iron oxide: quantitation of T2 relaxation effects. Pouliquen D; Lucet I; Chouly C; Perdrisot R; Le Jeune JJ; Jallet P Magn Reson Imaging; 1993; 11(2):219-28. PubMed ID: 8455432 [TBL] [Abstract][Full Text] [Related]
10. Biodegradation of magnetite dextran nanoparticles in the rat. A histologic and biophysical study. Okon E; Pouliquen D; Okon P; Kovaleva ZV; Stepanova TP; Lavit SG; Kudryavtsev BN; Jallet P Lab Invest; 1994 Dec; 71(6):895-903. PubMed ID: 7807971 [TBL] [Abstract][Full Text] [Related]
11. Trafficking of superparamagnetic iron oxide particles (Combidex) from brain to lymph nodes in the rat. Muldoon LL; Varallyay P; Kraemer DF; Kiwic G; Pinkston K; Walker-Rosenfeld SL; Neuwelt EA Neuropathol Appl Neurobiol; 2004 Feb; 30(1):70-9. PubMed ID: 14720178 [TBL] [Abstract][Full Text] [Related]
12. Biological properties of iron oxide nanoparticles for cellular and molecular magnetic resonance imaging. Schlorf T; Meincke M; Kossel E; Glüer CC; Jansen O; Mentlein R Int J Mol Sci; 2010 Dec; 12(1):12-23. PubMed ID: 21339973 [TBL] [Abstract][Full Text] [Related]
13. MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement. Guimaraes R; Clément O; Bittoun J; Carnot F; Frija G AJR Am J Roentgenol; 1994 Jan; 162(1):201-7. PubMed ID: 8273666 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of dextran stabilized superparamagnetic iron oxide nanoparticles for in vivo MR imaging of liver fibrosis. Saraswathy A; Nazeer SS; Nimi N; Arumugam S; Shenoy SJ; Jayasree RS Carbohydr Polym; 2014 Jan; 101():760-8. PubMed ID: 24299836 [TBL] [Abstract][Full Text] [Related]
16. MR contrast in mouse lymph nodes with subcutaneous administration of iron oxide particles: size dependency. Mori Y; Umeda M; Fukunaga M; Ogasawara K; Yoshioka Y Magn Reson Med Sci; 2011; 10(4):219-27. PubMed ID: 22214906 [TBL] [Abstract][Full Text] [Related]
17. Optimization of ultrasmall superparamagnetic iron oxide (P904)-enhanced magnetic resonance imaging of lymph nodes: initial experience in a mouse model. Yoo RE; Cho HR; Choi SH; Won JK; Kim JH; Sohn CH Anticancer Res; 2014 Oct; 34(10):5389-96. PubMed ID: 25275033 [TBL] [Abstract][Full Text] [Related]
18. Characterization of ultrasmall magnetite [correction of paramagnetic magnetite] particles as superparamagnetic contrast agents in MRI. Grimm J; Karger N; Lüsse S; Winoto-Morbach S; Krisch B; Müller-Hülsbeck S; Heller M Invest Radiol; 2000 Sep; 35(9):553-6. PubMed ID: 10982000 [TBL] [Abstract][Full Text] [Related]
19. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits. Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301 [TBL] [Abstract][Full Text] [Related]